SCHEMBL31430847

SCHEMBL31430847

COCOc1ccc(C)c(NC(=O)c2cc(C)cnc2Cl)c1C

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 1/20 0.45
▸ CHRNA7 P36544 3/20 0.37
▸ PDE4D Q08499 7/20 0.36
▸ PDE4B Q07343 6/20 0.36
▸ PDE4A P27815 5/20 0.36
▸ PDE4C Q08493 5/20 0.36
▸ CLCN2 P51788 1/20 0.36
▸ CTSA P10619 1/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ MITF O75030 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ KMT2A Q03164 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31430781 0.86 NR3C1 (0.37) KDRCHRNA7PDE4DPDE4BPDE4A
SCHEMBL31430868 0.86 PTGER4 (0.37) CHRNA7PDE4DPDE4BPDE4APDE4C
SCHEMBL31430866 0.78 MAPT (0.46) CHRNA7PDE4DPDE4BPDE4APDE4C
SCHEMBL31737736 0.70 PDE4D (0.44) CHRNA7PDE4DPDE4BPDE4APDE4C
SCHEMBL31430773 0.68 PDE4D (0.45) PDE4DPDE4BPDE4APDE4CKMT2A
SCHEMBL31492232 0.67 RAB9A (0.34) KDRPDE4BCLCN2NPC1RAB9A
SCHEMBL3732128 0.67 ATM (0.47) KDRNPC1RAB9AGAAKMT2A
SCHEMBL31430780 0.65 POLB (0.40) CHRNA7PDE4DPDE4BPDE4APDE4C
SCHEMBL11922277 0.62 KDR (0.52) KDRCHRNA7NPC1RAB9A
SCHEMBL13964183 0.62 KDR (0.47) KDRNPC1RAB9AKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025007784-A1 HETEROAROMATIC RING COMPOUND, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2025-01-09 — — WO disclosed
Send feedback